Muscle Weakness (Progressive)

Progressive muscle weakness can indicate neuromuscular conditions like ALS, where motor neurons degenerate, or autoimmune conditions like myasthenia gravis. Early identification of the underlying cause is critical for treatment decisions.

Body System: Neuromuscular

Related Diseases

• ALS (Amyotrophic Lateral Sclerosis) — Progressive weakness is the hallmark of ALS, caused by upper and lower motor neuron degeneration.
• Autoimmune Diseases — Myasthenia gravis, inflammatory myopathies, and MS can present with fluctuating or progressive weakness.

Related Compounds

• Riluzole
• Edaravone
• Methylcobalamin

Frequently Asked Questions

What causes progressive muscle weakness?

Progressive muscle weakness can stem from motor neuron diseases (ALS, SMA), neuromuscular junction disorders (myasthenia gravis), inflammatory myopathies (polymyositis), or metabolic conditions. EMG, nerve conduction studies, and blood tests help differentiate causes.

When should I see a doctor for muscle weakness?

Seek medical attention if weakness is progressive, affects daily activities, involves difficulty swallowing or breathing, or is accompanied by muscle twitching (fasciculations). Early diagnosis enables earlier access to disease-modifying therapies.

What emerging research exists for muscle weakness in ALS?

Current ALS research includes antisense oligonucleotides (tofersen for SOD1-ALS), CuATSM copper delivery, ultra-high dose methylcobalamin (approved in Japan 2024), and masitinib anti-neuroinflammation therapy. AI-powered research platforms help identify novel therapeutic combinations.